Economy

Teva Pharmaceutical Industries Limited

The firm presently has a $24.00 price objective on the stock. Finally, Mizuho raised Teva Pharmaceutical Industries Limited from a "neutral" rating to a "buy" rating and upped their target price for the company from $25.00 to $30.00 in a research report on Thursday, June 15th. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. ValuEngine downgraded Teva Pharmaceutical Industries Limited from a "buy" rating to a "hold" rating in a research note on Friday, September 1st. From the opening price, the stock has seen a change of 0.00% recently clocking in with a price of $17.25. Oppenheimer Holdings, Inc. restated a "buy" rating on shares of Teva Pharmaceutical Industries Limited in a report on Wednesday, May 31st. Teva Pharmaceutical Industries Limited is expected to give up sales by -4.52% in next year to $21.75B. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. The stock now has an average rating of "Hold" and a consensus price target of $30.91. Looking out over the past year, company shares have been recorded -66.51% off the 52 week high and 13.34% away from the low over the same period.Covering sell-side analysts have recently weighed in on shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA). The stock traded within a range of $17.07 and $17.42. The company's 50 day moving average price is $18.13 and its 200 day moving average price is $28.20. The company's market cap is $17.48 Billion, and the average volume is 20.34 Million.

Teva Pharmaceutical Industries Limited is a pharmaceutical company. Teva Pharmaceutical Industries Limited's payout ratio is -15.36%. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.06 by ($0.07).

Analysts believe that the company has the potential to earn average revenue of $5.63 Billion for the current quarter. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since September 25, 2016 and is downtrending. During the same quarter past year, the firm posted $1.25 earnings per share. Kistler Tiffany Companies LLC now owns 3,673 shares of the company's stock valued at $122,000 after acquiring an additional 1,571 shares in the last quarter. Teva Pharmaceutical Industries Limited's revenue was up 12.9% on a year-over-year basis. If you are accessing this report on another website, it was copied illegally and reposted in violation of US and global copyright & trademark legislation. The legal version of this report can be viewed at https://stocknewstimes.com/2017/09/26/teva-pharmaceutical-industries-limited-teva-price-target-cut-to-15-00-by-analysts-at-royal-bank-of-canada.html. "Acquires 1,295,794 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)" was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune.

November 05, 2017: Teva Pharmaceutical Industries Limited (TEVA) reported Q1 earnings of $1.06, beating consensus estimates of $1.03. Bridger Management Llc sold 1.09 million shares as Teva Pharmaceutical Inds Ltd (TEVA)'s stock declined 15.11%. PGGM Investments lifted its holdings in Teva Pharmaceutical Industries Limited by 12.0% during the 2nd quarter. Nordea Investment Management AB now owns 12,884,810 shares of the company's stock valued at $428,033,000 after purchasing an additional 311,894 shares in the last quarter. Northern Cross LLC grew its position in shares of Teva Pharmaceutical Industries Limited by 14.0% during the 2nd quarter.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) last issued its quarterly earnings results on Thursday, August 3rd. Northern Cross LLC now owns 17,795,579 shares of the company's stock valued at $591,169,000 after purchasing an additional 2,184,172 shares in the last quarter. Washington Bancshares owns 0.97% invested in Potlatch Corporation (NASDAQ:PCH) for 98,939 shares.

Teva Pharmaceutical Industries Limited is a pharmaceutical company. With almost 600 generic medicines available, Teva has the largest portfolio of FDA-approved generic products on the marketand holds the leading position in first-to-file opportunities, with over 100 pending first-to-files in the U.S. Currently, one in seven generic prescriptions dispensed in the U.S.is filled with a Teva generic product. The Company operates through two segments: Generic medicines and Specialty medicines. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions.



Like this

Latest


26 September 2017
Accident Compensation Corp Has $757000 Stake in McKesson Corporation (NYSE:MCK)
Riverhead Capital Management LLC's holdings in McKesson Corporation were worth $6,233,000 as of its most recent SEC filing. The company's net profit margin has achieved the current level of 2.4 percent and possesses 5.5 percent gross margin.

26 September 2017
Microsoft is targeting VMWare customers with its new cloud migration service
Now, Microsoft provides a new way to transfer a ridiculous amount of data (100TB ) with a rugged 45-pound Data Box to Azure. All of these updates and enhancements for Azure continue to show Microsoft's commitment to its cloud service.

26 September 2017
North Korean Foreign Minister: Trump Threat Was Declaration of War
If he echoes thoughts of Little Rocket Man, they won't be around much longer!" "We have not declared war on North Korea". In response , DPRK's top leader Kim Jong Un vowed to retaliate, saying Trump "will face results beyond his expectation".

26 September 2017
Bill Gates still refuses to use an iPhone
Microsoft's latest operating system, Windows 10, can power smartphones in addition to laptops, tablets and desktop computers. KERMIT-LIKE EX-MICROSOFT BOSS and poo drinker Bill Gates has admitted that he has started using an Android smartphone.

26 September 2017
Fitbit Announces Global Availability of Fitbit Ionic Smartwatch
You'll also be able to pick up Classic and Sport accessory bands for $30/£25 apiece or leather bands for $60/£50 each. This will allowing anyone with a bit of coding knowledge to build apps and clock faces for the Ionic.

26 September 2017
May and Varadkar to discuss Brexit plans
IFA president Joe Healy says the British Prime Minister's Brexit speech in Italy on Friday was disappointing. The Government is working on a "practical solution" to deal with the border issue, Downing Street said.

26 September 2017
OxygenOS 4.5.0 For OnePlus 3 and 3T Adds New Features
Other new features included in this new software version are the low priority notification and network speed in the status bar. This software package is identified by the manufacturer as the OxygenOS 4.5.0 which still runs on top of Android 7.1.1 Nougat.

26 September 2017
Inter Milan Hoping To Sign Mesut Ozil In January
Ozil has been recently linked with a move to Manchester United after struggling to create his best form at the Emirates. Juan Mata is in his final year of his contract and the German might be the replacement for the former Chelsea star.

26 September 2017
PH respects Malaysia's dissociation from ASEAN statement on Rohingya
Myanmar rejects the charge and says that most of the 400-odd people killed were insurgents. But she warned that more pressure must be put on Myanmar to take back their refugees.

26 September 2017
Founder of Clergy Sex Abuse Victims Group Dies at 61
She received a bachelor's degree from Saint Louis University, a master's degree in social work from Washington University in St. In a 2012 interview, she told the Tirbune that she never envisioned a combative relationship with the Catholic Church.



Recommended